Results 251 to 260 of about 153,978 (297)

Liver transplantation in malignant primary hepatic neoplasms

The American Journal of Surgery, 1992
Between April 1986 and August 1990, 151 liver transplantations were performed at our institution, 16 (11%) of them in 14 patients with primary hepatic tumors. There were 12 hepatocellular carcinomas, 1 angiosarcoma, and 1 Klatskin tumor. None of the tumors was resectable, and there was no preoperative evidence of extrahepatic tumoral extension ...
Enrique Moreno González, Ramon Gámez, Ignacio García, Ignacio González-Pinto, Carmelo Loinaz, Javier Ibañez, Julio Bercedo, Juan Carlos Palomo, Fermin Palma, Peter Vorwald, Damaso Riaño, Francisco Pérez Cerda, Pedro Dávila, Cesar Cisneros, Vincenzo Maffettone, Marcus Sciadini   +15 more
openaire   +2 more sources

Haploidentical Transplants for Myeloproliferative Neoplasms

2017
Allogeneic hematopoietic cell transplantation remains the only curative therapy available for patients with myeloproliferative neoplasms and is mostly performed for primary myelofibrosis or secondary myelofibrosis with high dynamic international scoring system-plus score, advanced (or refractory) chronic myelogenous leukemia, and chronic myelomonocytic
Monzr M. Al Malki, Stefan O. Ciurea, Richard E. Champlin   +2 more
openaire   +1 more source

Colorectal and anal neoplasms following liver transplantation

Colorectal Disease, 2010
AbstractObjective  Liver transplantation (LT) is the treatment of choice for end‐stage liver disease. The required immunosuppression increases the risk for developing malignancies. Some viruses play a crucial role. Data on neoplasms of the colon, rectum and anus in LT are limited.Method  A retrospective evaluation of the incidence and clinical course ...
J B, Albright, H, Bonatti, J, Stauffer, R C, Dickson, J, Nguyen, D, Harnois, C, Jeanpierre, R, Hinder, J, Steers, H, Chua, J, Aranda-Michel   +10 more
openaire   +2 more sources

Epidemiologic critique of literature on post‐transplant neoplasms in solid organ transplantation

Clinical Transplantation, 2009
Abstract:  As survival of transplant recipients improves, long‐term complications become more important. We reviewed epidemiologic literature on real‐world risks of de novo neoplasia post‐transplant. We searched the Medline/PubMed, Cochrane, and Embase databases for population‐based studies on risk of neoplasia from 1998 to 2005.
Lee L, Lanza, Lili, Wang, Teresa A, Simon, William D, Irish   +3 more
openaire   +2 more sources

Autologous Islet Transplantation in Patients Requiring Pancreatectomy for Neoplasm

Current Diabetes Reports, 2014
Autologous islet cell transplantation is a procedure performed to prevent or reduce the severity of diabetes after pancreatic resection. Autologous islet cell transplantation is being used almost exclusively in patients undergoing pancreatectomy because of painful, chronic pancreatitis, or multiple recurrent episodes of pancreatitis that is not ...
Balzano, Gianpaolo, PIEMONTI, LORENZO
openaire   +3 more sources

Neoplasms and Transplantation — Trading Swords for Plowshares

New England Journal of Medicine, 1997
The recent death of former U.S. Senator Paul Tsongas at the age of 55 from complications of bone marrow transplantation was a reminder that we have not cleared this treatment of its most difficult problems. The senator had received two marrow transplants — an autograft in 1986 to treat lymphoma, and an allograft in 1996 to treat the myelodysplastic ...
David P. Schenkein, Robert S. Schwartz
openaire   +1 more source

[Neoplasms in kidney transplant patients].

Actas urologicas espanolas, 1994
Our service performed a total of 619 kidney transplants between February 1980 and March 1993. Among them, 41 new neoplasias (6.6%) were diagnosed. Most frequent tumour was epithelioma (25) with a presentation age lower than in the normal population.
J M, Martínez Jabaloyas, J L, Ruiz Cerda, J M, Osca, J L, Perales Ruiz, R, Alfonso Gil, L, Pallardo, J F, Jiménez Cruz   +6 more
openaire   +1 more source

Malignant neoplasms following cardiac transplantation.

JAMA, 1978
Between Jan 6, 1968, and April 11, 1977, 124 patients underwent cardiac transplantation at Stanford University Medical Center, with a mean and median period of follow-up of 18.3 and 9.7 months, respectively. Malignant neoplasms developed in seven patients--three lymphoproliferative neoplasms, two skin cancers, one acute leukemia, and one colon ...
J G, Krikorian, J L, Anderson, C P, Bieber, I, Penn, E B, Stinson   +4 more
openaire   +3 more sources

[Malignant neoplasms and transplantation].

Innere Medizin (Heidelberg, Germany)
Malignant neoplasms constitute a major burden of morbidity and mortality in the general population. This necessitates intense screening of transplant candidates and even closer surveillance of immunosuppressed solid organ recipients. Active malignancy is an exclusion criterion to solid organ transplantation, with few exceptions, namely localized ...
Sibylle, von Vietinghoff, Steffen, Manekeller, Guido, Fechner, Peter, Brossart, Jörg, Kalff, Manuel, Ritter, Christian P, Strassburg   +6 more
openaire   +1 more source

[Malignant neoplasms and kidney transplantation].

Der Urologe. Ausg. A, 2010
Together with cardiovascular disorders and metabolic changes, malignant diseases are considered as great challenges in clinical transplantation. As far as long-term function of transplanted organs is concerned, an impact of malignancies is obvious. However, it is important to distinguish between neoplastic disease originating from preexisting lesions ...
H, Heynemann, A, Hamza, S, Wagner, R, Hoda, A, Schumann, P, Fornara   +5 more
openaire   +1 more source